Correlation of allele-specific HLA loss of heterozygosity in patients with cancer with driver mutations. Baseline heterogeneity of myeloid and stroma cells to predict pCR, baseline lymph node (LN) ...
Therapeutic implications of phosphoproteomics in molecular cancer diagnostics. Utility of [18F]FDG PET/CT in predicting pathological complete response to neoadjuvant therapy in breast cancer: A ...